Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Sedana Medical AB ( (SE:SEDANA) ).
Sedana Medical AB has announced the formation of its Nomination Committee for the 2026 Annual General Meeting, comprising members appointed by its three largest shareholders and the Chairman of the Board. This committee, representing 31.69% of the voting rights, will propose resolutions for the meeting, including board composition and auditor appointments, impacting the company’s governance and strategic direction.
The most recent analyst rating on (SE:SEDANA) stock is a Hold with a SEK14.00 price target. To see the full list of analyst forecasts on Sedana Medical AB stock, see the SE:SEDANA Stock Forecast page.
More about Sedana Medical AB
Sedana Medical AB is a pioneering medtech and pharmaceutical company specializing in inhaled sedation to enhance patient care during and after sedation. The company offers the Sedaconda ACD medical device and Sedaconda (isoflurane) pharmaceutical for inhaled sedation in mechanically ventilated intensive care patients. It operates with direct sales in several European countries and through distributors in other regions, and is listed on Nasdaq Stockholm.
Average Trading Volume: 305,447
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK1.27B
See more data about SEDANA stock on TipRanks’ Stock Analysis page.